These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4051321)

  • 1. The use of criteria for reversibility and obstruction to define patient groups for bronchodilator trials. Influence of clinical diagnosis, spirometric, and anthropometric variables.
    Eliasson O; Degraff AC
    Am Rev Respir Dis; 1985 Oct; 132(4):858-64. PubMed ID: 4051321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spirometric indices after bronchodilator test in obstructive lung disease.
    Mehrparvar AH; Mirmohammadi SJ; Sohrabi MM
    Acta Med Iran; 2010; 48(4):226-30. PubMed ID: 21279934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease.
    Hansen EF; Phanareth K; Laursen LC; Kok-Jensen A; Dirksen A
    Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1267-71. PubMed ID: 10194175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of bronchodilator response in patients with airway obstruction.
    Quadrelli SA; Roncoroni AJ; Montiel GC
    Respir Med; 1999 Sep; 93(9):630-6. PubMed ID: 10542976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Misidentification of airflow obstruction: prevalence and clinical significance in an epidemiological study.
    Pothirat C; Chaiwong W; Phetsuk N; Liwsrisakun C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():535-40. PubMed ID: 25792821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-bronchodilator spirometry reference values in adults and implications for disease management.
    Johannessen A; Lehmann S; Omenaas ER; Eide GE; Bakke PS; Gulsvik A
    Am J Respir Crit Care Med; 2006 Jun; 173(12):1316-25. PubMed ID: 16556696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When should a reversibility test be performed on patients with early stages of asthma and normal spirometry?
    Sposato B; Mariotta S; Ricci A
    J Asthma; 2008 Aug; 45(6):479-83. PubMed ID: 18612900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the bronchodilator test an useful tool to measure asthma control?
    Ferrer Galván M; Javier Alvarez Gutiérrez F; Romero Falcón A; Romero Romero B; Sáez A; Medina Gallardo JF
    Respir Med; 2017 May; 126():26-31. PubMed ID: 28427546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bronchial obstruction reversibility test in the assessment of COPD severity--controversies].
    Maskey-Warzechowska M; Pankowska M; Chazan R
    Pneumonol Alergol Pol; 2006; 74(1):68-71. PubMed ID: 17175980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The response pattern of patients with chronic airway obstruction to bronchodilators.
    Yang SC; Wu MC
    Taiwan Yi Xue Hui Za Zhi; 1989 Jul; 88(7):700-6. PubMed ID: 2809562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute bronchodilator trials in chronic obstructive pulmonary disease.
    Nisar M; Earis JE; Pearson MG; Calverley PM
    Am Rev Respir Dis; 1992 Sep; 146(3):555-9. PubMed ID: 1387772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
    Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
    Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of age upon airway obstruction and reversibility in adult patients with asthma.
    Bellia V; Cibella F; Cuttitta G; Scichilone N; Mancuso G; Vignola AM; Bonsignore G
    Chest; 1998 Nov; 114(5):1336-42. PubMed ID: 9824011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing two spirometric criteria of pre-bronchodilator and post-bronchodilator FEV1/FVC ratio in detecting air flow obstruction.
    Waheed Z; Irfan M; Haque AS; Siddiqui NH; Awan S; Syed B; Khan JA
    J Pak Med Assoc; 2011 Dec; 61(12):1172-5. PubMed ID: 22355960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung volume abnormalities and its correlation to spirometric and demographic variables in adult asthma.
    Jain VV; Abejie B; Bashir MH; Tyner T; Vempilly J
    J Asthma; 2013 Aug; 50(6):600-5. PubMed ID: 23521185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversibility prediction of chronic airways flow limitation by a new simple spirometric parameter.
    Dal Negro RW; Turco P; Pomari C; Zoccatelli O; Serra R
    Int J Clin Pharmacol Ther Toxicol; 1983 May; 21(5):263-5. PubMed ID: 6862732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
    Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bronchodilator response in elderly patients].
    Quadrelli SA; Roncoroni AJ; Sacerdotti A
    Medicina (B Aires); 2001; 61(3):257-61. PubMed ID: 11474869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [FEV1 after three years of observation in patients with bronchial asthma and patients with chronic obstructive pulmonary disease].
    Zagdańska R; Grzelewska-Rzymowska I
    Pneumonol Alergol Pol; 2005; 73(2):142-7. PubMed ID: 16756143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group.
    Brand PL; Quanjer PH; Postma DS; Kerstjens HA; Koëter GH; Dekhuijzen PN; Sluiter HJ
    Thorax; 1992 Jun; 47(6):429-36. PubMed ID: 1496502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.